Related references
Note: Only part of the references are listed.Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood-Brain Barrier Measured by Quantitative Targeted Proteomics
Sarah Billington et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
In Vitro-In Vivo Extrapolation of Key Transporter Activity at the Blood-Brain Barrier
Patrick E. Trapa et al.
DRUG METABOLISM AND DISPOSITION (2019)
LC-MS/MS-based quantification of efflux transporter proteins at the BBB
David Gomez-Zepeda et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
Proteomic Quantification of Human Blood-Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients
Zubida M. Al-Majdoub et al.
MOLECULAR PHARMACEUTICS (2019)
ABC Transporters in Neurological Disorders: An Important Gateway for Botanical Compounds Mediated Neuro-Therapeutics
Niraj Kumar Jha et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Age-related ultrastructural changes of the basement membrane in the mouse blood-brain barrier
Laura Cristina Ceafalan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics
Yijun Pan et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
ATP-binding cassette transporter-2 (ABCA2) as a therapeutic target
Warren Davis et al.
BIOCHEMICAL PHARMACOLOGY (2018)
The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM
Steffen E. Storck et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Age-dependent changes at the blood-brain barrier. A Comparative structural and functional study in young adult and middle aged rats
Luca Bors et al.
BRAIN RESEARCH BULLETIN (2018)
ATP-Binding Cassette Transporter A Subfamily 8 Is a Sinusoidal Efflux Transporter for Cholesterol and Taurocholate in Mouse and Human Liver
Kazunari Sasaki et al.
MOLECULAR PHARMACEUTICS (2018)
Preventing P-gp Ubiquitination Lowers A beta Brain Levels in an Alzheimer's Disease Mouse Model
Anika M. S. Hartz et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism
Qingyi Ma et al.
MOLECULAR NEURODEGENERATION (2018)
An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter
Pavitra Kannan et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Age-associated physiological and pathological changes at the blood-brain barrier: A review
Franciska Erdo et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates
Clemens Braun et al.
MOLECULAR PHARMACEUTICS (2017)
Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier
Doreen Osgood et al.
NEUROBIOLOGY OF AGING (2017)
Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats
Kelly M. DeMars et al.
JOURNAL OF EXPERIMENTAL NEUROSCIENCE (2017)
Transporters as Drug Targets in Neurological Diseases
H. Qosa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Pilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood-Brain Barrier
M. Bauer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
PET Tracers for Imaging of ABC Transporters at the Blood-Brain Barrier: Principles and Strategies
Gert Luurtsema et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway
Anika M. S. Hartz et al.
JOURNAL OF NEUROSCIENCE (2016)
Whole-Body Distribution and Radiation Dosimetry of 11C-Elacridar and 11C-Tariquidar in Humans
Martin Bauer et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
18F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier
Jeih-San Liow et al.
NEUROIMAGE (2016)
Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease
Thibaud Thiollier et al.
SYNAPSE (2016)
Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD)
Tuan Minh Do et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
BCRP protein levels do not differ regionally in adult human livers, but decline in the elderly
Zoe Riches et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
The Concept of Fraction of Drug Transported (f(t)) With Special Emphasis on BBB Efflux of CNS and Antiretroviral Drugs
B. Prasad et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
The ATP-Binding Cassette Transporter-2 (ABCA2) Overexpression Modulates Sphingosine Levels and Transcription of the Amyloid Precursor Protein (APP) Gene
Warren Davis
CURRENT ALZHEIMER RESEARCH (2015)
P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations
Catherine Chiu et al.
NEUROBIOLOGY OF AGING (2015)
Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease
Anand K. Deo et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
An In Vivo Microdialysis Study of FLZ Penetration through the Blood-Brain Barrier in Normal and 6-Hydroxydopamine Induced Parkinson's Disease Model Rats
Jinfeng Hou et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Advances in PET Imaging of P-Glycoprotein Function at the Blood-Brain Barrier
Stina Syvanen et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Why Clinical Modulation of Efflux Transport at the Human Blood-Brain Barrier Is Unlikely: The ITC Evidence-Based Position
J. C. Kalvass et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Quantitative Atlas of Blood-Brain Barrier Transporters, Receptors, and Tight Junction Proteins in Rats and Common Marmoset
Yutaro Hoshi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Human Intestinal Transporter Database: QSAR Modeling and Virtual Profiling of Drug Uptake, Efflux and Interactions
Alexander Sedykh et al.
PHARMACEUTICAL RESEARCH (2013)
The Use of Microdialysis Techniques in Mice to Study P-gp Function at the Blood-Brain Barrier
Istvan Sziraki et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Down-regulation of the ATP-binding Cassette Transporter 2 (Abca2) Reduces Amyloid-β Production by Altering Nicastrin Maturation and Intracellular Localization
Vasiliki Michaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
P-Glycoprotein Function at the Blood-Brain Barrier: Effects of Age and Gender
Danielle M. E. van Assema et al.
MOLECULAR IMAGING AND BIOLOGY (2012)
Low-density lipoprotein receptor-related protein 1: A physiological Aβ homeostatic mechanism with multiple therapeutic opportunities
Abhay P. Sagare et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Acetaminophen-Induced Hepatotoxicity and Protein Nitration in Neuronal Nitric-Oxide Synthase Knockout Mice
Rakhee Agarwal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
The Role of the ATP-Binding Cassette Transporter P-Glycoprotein in the Transport of β-Amyloid Across the Blood-Brain Barrier
Silke Vogelgesang et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up
Sagar Agarwal et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
P-Glycoprotein Activity in Human Caucasian Male Lymphocytes Does Not Follow its Increased Expression During Aging
Vania Vilas-Boas et al.
CYTOMETRY PART A (2011)
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
Yasuo Uchida et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Quantitative Membrane Protein Expression at the Blood-Brain Barrier of Adult and Younger Cynomolgus Monkeys
Katsuaki Ito et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels
Ramzi Shawahna et al.
MOLECULAR PHARMACEUTICS (2011)
Age-dependent decline of blood-brain barrier P-glycoprotein expression in the canine brain
A. Pekcec et al.
NEUROBIOLOGY OF AGING (2011)
Blood-Brain Barrier (BBB) Pharmacoproteomics: Reconstruction of In Vivo Brain Distribution of 11 P-Glycoprotein Substrates Based on the BBB Transporter Protein Concentration, In Vitro Intrinsic Transport Activity, and Unbound Fraction in Plasma and Brain in Mice
Yasuo Uchida et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Quinidine as an ABCB1 Probe for Testing Drug Interactions at the Blood-Brain Barrier: An In Vitro In Vivo Correlation Study
Istvan Sziraki et al.
JOURNAL OF BIOMOLECULAR SCREENING (2011)
Regulation of BCRP (ABCG2) and P-Glycoprotein (ABCB1) by Cytokines in a Model of the Human Blood-Brain Barrier
Birk Poller et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2010)
Kinetic Analysis of the Cooperation of P-Glycoprotein (P-gp/Abcb1) and Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting the Brain and Testis Penetration of Erlotinib, Flavopiridol, and Mitoxantrone
Hiroshi Kodaira et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid-β in a Mouse Model of Alzheimer's Disease
Anika M. S. Hartz et al.
MOLECULAR PHARMACOLOGY (2010)
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease
Robert D. Bell et al.
ACTA NEUROPATHOLOGICA (2009)
Limited Brain Distribution of [3R,4R,5S]-4-Acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate Phosphate (Ro 64-0802), a Pharmacologically Active Form of Oseltamivir, by Active Efflux across the Blood-Brain Barrier Mediated by Organic Anion Transporter 3 (Oat3/Slc22a8) and Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4)
Atsushi Ose et al.
DRUG METABOLISM AND DISPOSITION (2009)
Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET
Martin Bauer et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro
Magdalena von Wedel-Parlow et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration
Anna L. Bartels et al.
NEUROBIOLOGY OF AGING (2009)
Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA
A. L. Bartels et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation
L. M. Roberts et al.
NEUROSCIENCE (2008)
Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson's disease
A. L. Bartels et al.
PARKINSONISM & RELATED DISORDERS (2008)
The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK–PD experiments
Paulien G.M. Ravenstijn et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2007)
MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-β peptides -: Implications for the mechanisms of Aβ clearance at the blood-brain barrier
Diana Kuhnke et al.
BRAIN PATHOLOGY (2007)
Increased permeability of blood-brain barrier on the hippocampus of a murine model of senescence
Carme Pelegri et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2007)
Correlation of induction of ATP binding cassette transporter A5 (ABCA5) and ABCB1 mRNAs with differentiation state of human colon tumor
Sumio Ohtsuki et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of ( R )-[11C]verapamil and positron emission tomography
Rolf Toornvliet et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography
L Sasongko et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells
Y Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Expression and immunolocalization of the multidrug resistance proteins, Mrp1-Mrp6 (ABCC1-ABCC6), in human brain
AT Nies et al.
NEUROSCIENCE (2004)
The Role of P-glycoprotein in Cerebral Amyloid Angiopathy; Implications for the Early Pathogenesis of Alzheimer's Disease
Silke Vogelgesang et al.
CURRENT ALZHEIMER RESEARCH (2004)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse
WA Banks et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2000)
Share Paper
